Xingjuan Shi

Dr. Xingjuan Shi


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2017 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
XSXingjuan Shi
Xingjuan Shi
SVSubodh Verma
Subodh Verma
JYJunghwa Yun
Junghwa Yun
KBKoroboshka Brand-Arzamendi
Koroboshka Brand-Arzamendi
KSKrishna Singh
Krishna Singh
XWXiao-Yan Wen
Xiao-Yan Wen

24 July 2017 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
XSXingjuan Shi
Xingjuan Shi
XSXiaoou Sun
Xiaoou Sun

1 May 2021 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
HZHao Zhang
Hao Zhang
BLBo Liu
Bo Liu
XSXingjuan Shi
Xingjuan Shi
XSXiaoou Sun
Xiaoou Sun

3 May 2018 in Amino Acids
Verified
Journal Article
Closed access
PDF file
XSXingjuan Shi
Xingjuan Shi
RCRu Chen
Ru Chen
YZYu Zhang
Yu Zhang
JYJunghwa Yun
Junghwa Yun
KBKoroboshka Brand-Arzamendi
Koroboshka Brand-Arzamendi
XWXiao-Yan Wen
Xiao-Yan Wen

29 September 2020 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
XSXingjuan Shi
Xingjuan Shi
YZYu Zhang
Yu Zhang
RCRu Chen
Ru Chen
YGYijie Gong
Yijie Gong
MZMingming Zhang
Mingming Zhang
XWXiao-Yan Wen
Xiao-Yan Wen
Cardiac hypertrophy is a common pathological change in patients with progressive cardiac function failure, which can be caused by hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) or arterial hypertension. Despite years of study, there is still limited knowledge about the underlying molecular mechanisms for cardiac hypertrophy. NDUFA7, a subunit of NADH:ubiquinone oxidoreductase (complex I), has been reported to be a novel HCM associated gene. However, the biological role of NDUFA7 in heart remains unknown. In this study, we found that NDUFA7 exhibited high expression in the heart, and its level was significantly decreased in mice model of cardiac hypertrophy. Moreover, we demonstrated that ndufa7 knockdown in developing zebrafish embryos resulted in cardiac development and functional defects, associated with increased expression of pathological hypertrophy biomarkers nppa (ANP) and nppb (BNP). Mechanistic study demonstrated that ndufa7 depletion promoted ROS production and calcineurin signalling activation. Moreover, NDUFA7 depletion contributed to cardiac cell hypertrophy. Together, these results report for the first time that ndufa7 is implicated in pathological cardiac hypertrophy.

26 January 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
YZYu Zhang
Yu Zhang
JYJiayu Yao
Jiayu Yao
MZMingming Zhang
Mingming Zhang
YWYushan Wang
Yushan Wang
XSXingjuan Shi
Xingjuan Shi
Mitochondria-associated endoplasmic reticulum membranes (MAMs) are formed by physical connections of the endoplasmic reticulum and mitochondria. Over the past decades, great breakthroughs have been made in the study of ER-mitochondria communications. It has been identified that MAM compartments are pivotal in regulating neurological function. Accumulating studies indicated that MAMs participate in the development of cardiovascular diseases. However, the specific role of MAMs in heart failure remains to be fully understood. In this article, we first summarize the structural and functional properties of MAM and MAM-associated proteins. We then focus on the roles of MAMs in myocardial infarction, cardiomyopathy and heart failure, and discuss the involvement of MAMs in disease progression and treatment. Elucidating these issues may provide important insights into therapeutic intervention of heart failure.